Danish Evaluation of Your Heart Forecast.

Summary

Under 50% of patients diagnosed with hypertension and treated in general practice, have reached a blood pressure within the recommended levels of the national guideline. Compliance is the main problem for these patients, but effective tools for increasing patient compliance are missing. The objective is to evaluate the risk-assessment and risk-communication tool: "Your Heart Forecast", to see if it can improve patient compliance, health literacy and empowerment.

Patients will be followed in a cluster-randomised controlled trial in the setting of general practice, using surveys at inclusion and after 6 and 12 months. Besides surveys, the participants' blood pressure will be measured as a hard outcome and data will be drawn from various patient databases. After 6 months, qualitative interviews will be conducted, with a subgroup of patients from the intervention group.

It is expected to find whether the use of Your Heart Forecast can lower patients' blood pressure and/or increase their compliance, health literacy and empowerment. The aim is to show if an increase in general health literacy and patient empowerment, as measured by Patient Activation Measure(PAM13) can be seen.

The investigators hope to reveal whether this software can improve patient compliance and thereby be a reasonable tool to implement in the national blood pressure control program. In further studies, it should be shown if the cost of using this program is far less than expenses for hospitalisation due to complications and comorbidity to hypertension.

Conditions

• Risk Communication
• Cardiovascular Risk Factor

Interventions

OTHER

Your Heart Forecast

1 year follow up with Your Heart Forecast and a follow-up email every 2 weeks.

Sponsors & Collaborators

• Region of Southern Denmark

  collaborator OTHER

• Odense Patient Data Explorative Network

  collaborator OTHER

• ENIGMA Solutions Limited

  collaborator UNKNOWN

• Lilly & Herbert Hansens Foundation

  collaborator UNKNOWN

• The A. P. Møller and Chastine McKinney Møller Foundation

  collaborator UNKNOWN

• University of Southern Denmark

  lead OTHER

Principal Investigators

• Jesper B Nielsen, Professor, PhD · Research Unit of General Practice, University of Southern Denmark

• Anders E Jensen, M.D. · Research Unit of General Practice, University of Southern Denmark

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

35 Years

Max Age

75 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2019-03-27

Primary Completion

2022-10-31

Completion

2022-12-31

Countries

• Denmark

Study Locations